We are live on !
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $19.3M invested in Tonix Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
2,633% more call options, than puts
Call options by funds: $82K | Put options by funds: $3K
6.11% less ownership
Funds ownership: 48.54% → 42.44% (-6.1%)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $11.3M
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$82K
Puts
$3K
Net Calls
+$79K
Net Calls Change
-$1.55M
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$4.33M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$2.68M |
| 3 |
Avoro Capital Advisors
New York
|
-$2.61M |
| 4 |
Turner Investments
Berwyn,
Pennsylvania
|
-$936K |
| 5 |
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$529K |